Literature DB >> 25003766

Rheumatoid arthritis: citrullination alters the inflammatory properties of chemokines in inflammatory arthritis.

Jenny Buckland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25003766     DOI： 10.1038/nrrheum.2014.112

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Citrullination of epithelial neutrophil-activating peptide 78/CXCL5 results in conversion from a non-monocyte-recruiting chemokine to a monocyte-recruiting chemokine.

Authors:  Ken Yoshida; Olexandr Korchynskyi; Paul P Tak; Takeo Isozaki; Jeffrey H Ruth; Phillip L Campbell; Dominique L Baeten; Danielle M Gerlag; M Asif Amin; Alisa E Koch
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995
  1 in total
  3 in total

1.  Tubulointerstitial Nephritis in an Advanced Melanoma Patient Treated with Encorafenib plus Binimetinib Combination Therapy.

Authors:  Yumi Kambayashi; Kentaro Ohuchi; Hiromu Chiba; Erika Tamabuchi; Tasuku Nagasawa; Yoshihide Asano; Taku Fujimura
Journal:  Case Rep Oncol       Date:  2022-05-02

2.  Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma.

Authors:  Taku Fujimura; Takanori Hidaka; Yumi Kambayashi; Sadanori Furudate; Aya Kakizaki; Hisayuki Tono; Akira Tsukada; Takahiro Haga; Akira Hashimoto; Ryo Morimoto; Takuhiro Yamaguchi; Tadao Takano; Setsuya Aiba
Journal:  Oncotarget       Date:  2017-04-13

3.  Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study.

Authors:  Taku Fujimura; Yota Sato; Kayo Tanita; Yumi Kambayashi; Atsushi Otsuka; Yasuhiro Fujisawa; Koji Yoshino; Shigeto Matsushita; Takeru Funakoshi; Hiroo Hata; Yuki Yamamoto; Hiroshi Uchi; Yumi Nonomura; Ryota Tanaka; Megumi Aoki; Keisuke Imafuku; Hisako Okuhira; Sadanori Furudate; Takanori Hidaka; Setsuya Aiba
Journal:  Oncotarget       Date:  2018-02-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.